Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Other Working Capital Changes (2021 - 2025)

Historic Other Working Capital Changes for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to -$4.0 million.

  • Biote's Other Working Capital Changes fell 19460.25% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year increase of 3970.17%. This contributed to the annual value of -$2.9 million for FY2024, which is 15319.31% down from last year.
  • According to the latest figures from Q3 2025, Biote's Other Working Capital Changes is -$4.0 million, which was down 19460.25% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, Biote's Other Working Capital Changes ranged from a high of $5.3 million in Q2 2023 and a low of -$4.0 million during Q3 2025
  • For the 5-year period, Biote's Other Working Capital Changes averaged around $147105.3, with its median value being -$545000.0 (2025).
  • As far as peak fluctuations go, Biote's Other Working Capital Changes tumbled by 146699.03% in 2022, and later surged by 157336.68% in 2025.
  • Over the past 5 years, Biote's Other Working Capital Changes (Quarter) stood at -$1.7 million in 2021, then decreased by 2.82% to -$1.7 million in 2022, then rose by 0.87% to -$1.7 million in 2023, then skyrocketed by 59.24% to -$693000.0 in 2024, then plummeted by 482.83% to -$4.0 million in 2025.
  • Its Other Working Capital Changes was -$4.0 million in Q3 2025, compared to $2.9 million in Q2 2025 and -$545000.0 in Q1 2025.